Health

Dueling federal rulings leave abortion drug access in limbo, as Oregon, Washington prepare to fight back

By Amelia Templeton (OPB) and Lillian Mongeau Hughes (OPB)
April 7, 2023 11:51 p.m. Updated: April 8, 2023 6:24 p.m.

A federal court in Texas has ruled that the 23-year-old FDA approval of mifepristone should be overturned. But a federal court in Washington has ruled the FDA must continue to make the drug available in some states.